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Abstract: Carotid adventitia vasa vasorum neovascularization (VVn) is associated with the initial stages of 
arteriosclerosis and with the formation of unstable plaque. However, techniques to accurately quantify that 
neovascularization in a standard, fast, non-invasive, and efficient way are still lacking. The development of such 
techniques holds the promise of enabling wide, inexpensive, and safe screening programs that could stratify 
patients and help in personalized preventive cardiovascular medicine. In this paper, we review the recent 
scientific literature pertaining to imaging techniques that could set the stage for the development of standard 
methods for quantitative assessment of atherosclerotic plaque and carotid VVn. We present and discuss the 
alternative imaging techniques being used in clinical practice and we review the computational developments 
that are contributing to speed up image analysis and interpretation. We conclude that one of the greatest 
upcoming challenges will be the use of machine learning techniques to develop automated methods that assist in 
the interpretation of images to stratify patients according to their risk. 
Key words: Carotid Imaging Techniques; Vasa Vasorum Neovascularization; Atherosclerotic Process, 
Automatic Methods. 
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1. Introduction 
Atherosclerosis is a chronic progressive inflammatory disease of the arterial wall characterized by the 
localized thickening of that wall. This happens through the accumulation of inflammatory cells and lipid 
substances, combined with the proliferation of vascular smooth muscle cells, ultimately leading to the 
formation of atherosclerotic plaques (1,2). 
In the normal carotid artery there is an extensive network of vasa vasorum (VV) in the adventitia that arise 
from branch points of parent arteries. Under physiological conditions, this specialized microvasculature 
delivers nutrients and oxygen to the outer layers of the arterial wall (2–6). In healthy states, microvessels 
arising from the vasa vasorum are spatially limited to the adventitia and outer media, and will only move 
towards and invade the intima during inflammatory processes that accompany atherosclerosis initiation and 
progression (5,7,8). According to this ―outside-in‖ hypothesis, vascular inflammation and vasa vasorum 
neogenesis is initiated in the adventitia and progresses inward toward the intima (3,9). Initiation and expansion 
of VV neovascularization (VVn) remain incompletely understood (2). Nevertheless, it is clear that changes in 
physiological vascular conditions, endothelial injuries, or other events that cause dysfunction and alter 
homeostasis can induce the expansion of VV. Neovascularization resulting from that expansion precedes 
increases in the thickness of the carotid intima-media and in the development of atherosclerotic plaque (6,10), 
further playing a significant role in progression and destabilization of that plaque (2,4). In fact, histological 
studies of human atherosclerotic plaques revealed that symptomatic patients had a denser network of VV than 
patients with asymptomatic disease (2,11–13). 
It is clear that a large scale use of histological methods to evaluate atherosclerotic progression in live 
patients is unfeasible. The development of alternative, non-invasive, methods to evaluate VVn as a proxy for 
atherosclerosis progression is thus an important goal. Imaging methods are obvious candidates for this role, 
and magnetic resonance imaging (MRI), contrast enhanced ultrasound (CEUS), and computed tomography 
(CT) are currently used in clinical practice for the visualization of anatomical structures in the adventitia VV 
(14). Still, initial validation of these techniques required that their results be compared to histological studies. 
In fact, it was shown that the intensity of histological markers for neovascularization significantly correlates 
with the quantification of neovascularization through imaging methods (11,15,16). The great objective of these 
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clinical tools, based on non-invasive image techniques, is the stratification of the risk level of patients (even in 
stages without plaque), and the assessment the vulnerability of the plaque (17). 
This review starts by a brief description of invasive imaging techniques (Section 2), followed by a concise 
appraisal of features and limitations of the various non-invasive imaging methods being used for quantification 
of VVn (Section 3). It then summarizes the most relevant clinical findings brought about by the use of imaging 
techniques in the context of VVn and atherosclerosis (Section 4). This is trailed by a presentation of the 
processing methods used to extract information from the images (Section 5). The discussion (Section 6) then 
assesses how current methodological limitations and challenges present opportunities for future technological 
development. The paper concludes that better automated analysis methods could have a significant impact on 
the use of imaging methods to assess and stratify cardiovascular risk, remarking that machine learning and 
artificial intelligence methods are expected to have an important role in this. 
2. Invasive Imaging Techniques for VV Quantification 
Intravascular medical imaging methods collect images from the inside of blood vessels using specially 
designed catheters with a miniaturized probe attached to their distal end. These methods acquire images with 
higher resolution than non-invasive alternatives (18).Intravascular ultrasound (IVUS), Optical coherence 
tomography (OCT), and Near-infrared spectroscopy (NIRS) are imaging techniques that have recently been 
used for assessment of VVn (19–21). IVUS uses ultrasound technology to generate cross-sectional images of 
the lumen and walls of larger blood vessels, with a resolution of 150–300 µm (20,21). OCT uses near-infrared 
light to generate cross-sectional intravascular images, with a resolution of 10–20 µm (21). NIRS uses infrared 
spectroscopy to automatically assess the lipid content in atherosclerotic plaques, without providing visual 
images of plaque morphology or quantifying VVn (21).  
Indocyanine green (ICG) fluorescence angiography is widely used to evaluate the blood flow in the 
operative field, for example during carotid endarterectomy. Indocyanine green (ICG) emits fluorescence in the 
far-red domain under light excitation and has been used to study the neovascularization of plaques in carotid 
(7,8). This was done using a surgical microscope, where the surgical field is illuminated using a laser-
fluorescence imaging device. After ICG was administered intravenously, the perfusion of the affected area was 
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visualized by the fluorescence signal and diagnosed by visual inspection, either in real time or by looking at 
digitally recorded videos. This technique allows the evaluation of inwardly projecting neovessels. It also 
provides a method to evaluate the nutrient supply route for these neovessels, because endothelial neovessels 
are immediately visible, while vasa vasorum show delayed  fluorescence (7,8). 
The necessary invasiveness of these techniques is a limitation for their use in preventive care programs that 
aim at stratifying the population and assess cardiovascular risk level in individual patients. Intravascular 
imaging methods are outside the scope of this review. We focus only on non-invasive techniques. 
3. Non-Invasive Imaging Techniques for VV quantification 
The list of current non-invasive imaging methods being used for carotid analysis includes: CT, MRI and 
CEUS (14). Molecular imaging is a type of medical imaging that provides detailed information of what is 
happening inside the body. For CT and CEUS is necessary to use an imaging agent that allows to visualize 
physiologic activities such as chemical processes from the metabolism, oxygen consumption or blood flow. 
Magnetic resonance spectroscopy is able to measure chemical levels in the body, without the use of an 
imaging agent. 
For the main techniques used for carotid VV assessment, non-invasive techniques were presented, and 
molecular imaging modalities were also referred since they have some advantages over traditional screening 
methods. 
Computerized Tomography 
CT uses ionizing radiation to reconstruct an image of the carotid and its walls, based on the differential x-ray 
attenuation of body tissue (22). During contrast-enhanced CT of arteries, a small fraction of the contrast media 
from the artery lumen enters the VV in the wall. The CT number of the wall is proportional to the spatial 
density of the VV (23). Example CT for carotid visualization in Figure 1 (24). 
The main advantage of CT is that it generates reproducible images of high resolution that are operator-
independent (24). The spatial resolution of CT can be further increased using image deconvolution, an 
approach that reduces blooming effects and enhances detection of increased VV (23,25). 
CT imaging has some disadvantages. First, there is a risk for the patient associated with the use of iodinated 
contrast material to obtain tissue images. Second, there are extensive motion artifacts inherently associated 
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with arterial pulsations or other physiological movements(24,26,27). These disadvantages lead us to think that 
carotid CT imaging is unlikely to play a major role as a screening tool for large scale analysis of arterial VVn 
in the context of cardiovascular disease (28). 
 
Figure 1: CT image showing ulcerations in right carotid bifurcation plaque (white arrow). 
Reproduced from (24), Doi: 10.4103/0971-3026.113616 
Magnetic resonance imaging 
One of the techniques that relies on transport for contrast is perfusion imaging, which quantifies the entry and 
extravasation of intravenously injected contrast agents into the plaque. The combined use of contrast agents 
with MRI forms the basis of Dynamic contrast enhanced MRI (DCE-MRI) and permits the assessment of both, 
neovascular architecture and functional characteristics of blood vessels (29). DCE-MRI measures the tissue 
contrast enhancement–time curve after intravenous injection of a bolus of contrast material, estimating kinetic 
parameters that describe the blood plasma fraction (vp), extracellular extravascular volume fraction (ve), and a 
kinetic parameter K
trans
. K
trans
 characterizes the transfer of the contrast agent from plasma to the extravascular 
space (for example, the adventitia), reflecting microvascular flow, permeability, and surface area (Figure2 (7)) 
(30). The intensity level of images during MRI can be adjusted by changing the sequence parameters of the 
magnetic pulses used for image acquisition. Using appropriate adjusted pulses one is able to evaluate the 
magnetic resonance signal intensity of the carotid plaque components (31). 
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a)  b)  
Figure 2: MRI of carotid vasa vasorum. a) Display of the kinetic modelling: Regions with flowing blood, such 
as the carotid artery lumen appear in red; vp, regions with rapid transfer, such as the vessel adventitia (arrows) 
appear in green: K
trans
. b) Representative sequence of DCE-MRI frames obtained before (image frame N = 1) 
and other frames after bolus injection of the contrast agent. 
Reproduced, with permission, from (7), https://doi.org/10.1148/radiol.11101264 
DCE-MRI enables a high-resolution characterization of both vessel structure, with the advantage of 
avoiding the ionizing radiation that is needed for CT imaging (28), (32). An important limitation of DCE-MRI 
is associated with the estimation of K
trans
. That estimation is only accurate if the blood vessel has a minimum 
wall thickness of 2 mm, precluding the use of the technique to study arteries with thinner walls (29). Other 
important limitations of the technique are its cost and its longer scanning times (28), both of which do not 
bode well for a widespread use of the technique in large scale screening programs. 
Contrast-enhanced ultrasonography 
CEUS is a modality for vascular imaging that combines ultra-sonograms with contrast microbubbles (33). 
CEUS is sensitive to changes in the blood flow and permits acquiring tissue perfusion information that enables 
the visualization of the adventitial network of VV in human carotid arteries. CEUS imaging enhances the 
vessel lumen and, consequently, provides complete visualization of the carotid artery vasculature, luminal 
surfaces, near and far wall, and adventitial and intraplaque VVn (Figure 3 (34)).  
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Figure 3: Contrast–enhanced ultrasound (CEUS) for assessing neo-vascularization of carotid plaque. Stenotic 
carotid plaque marked yellow-orange color of the contrast agent filling the lumen of the carotid artery. CEUS 
contrast effects are visible within the carotid plaque (yellow square), indicating plaque neovascularization. 
Immunohistological evaluation of the plaque area. 
Reproduced, with permission, from (34), Doi: https://doi.org/10.1371/journal.pone.0175331.g001 
Advantages of CEUS include that it is cost-effective, it can be performed at the bedside, it uses no ionizing 
radiation, and it has no nephrotoxicity. Furthermore, the technique combines a submillimetre resolution with 
the capability to detect individual microbubbles and provides diagnostic information with an accuracy that is 
comparable to that of CT and MRI (22,35,36). 
Important limitations of CEUS are its dose-dependency and the nonlinear propagation artifact known as 
pseudo-enhancement, which occurs in the far wall adventitia of the carotid artery (37,38). This artifact 
strongly advices against the use of that wall for the VV assessment in CEUS imaging. An additional limitation 
of this method is its dependency on the operator. The variety of alternative procedures used for the analysis of 
the contrast enhancement limit the comparability of results from different centres. The creation of a common, 
reproducible, and well-established protocol for CEUS is essential to overcome that problem and enable 
multicentre studies that potentiate large-scale use of CEUS imaging for cardiovascular risk stratification. Also, 
the accuracy of CEUS in plaque analysis decreases for heavily calcified plaques that create acoustic shadows 
(5,29,39). This is important because acoustic shadowing limits the assessment of stenosis severity and other 
plaque characteristics (40,41). The use of specialized software, implementing blooming-reducing algorithms, 
to analyse images with acoustic shadows can mitigate the errors in image evaluation and enhance image 
quality and detection of VV (23). 
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4. Clinical Studies 
The process of VVn is mainly associated to inflammatory mechanisms that are triggered in a wide range of 
pathologies: HIV, diabetes, chronic kidney disease, psoriasis, obesity, cardiovascular disease and events, etc. 
(42–46). In fact, (42–46) are only a few of the examples that emphasize the importance of VV assessment in 
multiple clinical contexts and studies, and accentuate the relevance of using imaging technology to investigate 
VVn. 
We will now briefly discuss reported clinical studies using non-invasive imaging methods to evaluate VVn 
of the human carotid in the context of different pathologies. These studies emphasize the congruence of results 
between non-invasive imaging methods and histological tissue analysis and/or reveal important clinical 
results. A summary of the studies is presented in Table 1. 
Computerized Tomography 
The correlation between CT and histological images in the context of carotid VV and plaque evaluation is high 
(r=0.91 for fatty plaques, r=0.85 for mixed plaques and r=0.95 for calcified plaques) (47,48). Encouraged by 
these results, CT was used to screen carotid stenosis (26,49,50). Plaque volume, degree of stenosis and 
composition can be assessed using the method, emphasizing the usefulness of this and other imaging 
techniques as tools for risk stratification (51). 
Magnetic resonance imaging 
Several comparative analyses revealed a good agreement between the results obtained by using DCE-MRI 
to evaluate plaque and adventitia VVn and those obtained through histological analysis of surgical specimens 
(52,53,55,56,67,68). Furthermore, Kerwin et al. showed that K
trans
 in the carotid adventitia in the presence of 
plaques provides a quantitative proxy for the extent of VVn (55,56). 
DCE-MRI can be used to estimate arterial and plaque calcification, loosening of the matrix, or 
haemorrhages, by measuring the response to a variety of magnetic pulses (53,54,69,70). The ability of DCE-
MRI to measure these characteristics of the atherosclerotic plaque allows the identification of high-risk 
plaques (71–73) and opened new uses for the technique. For example, L. Dong proposed its use for assessing 
the therapeutic response of VV in patients with atherosclerotic plaque (29). 
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TABLE 1. Clinical studies of human carotid VV evaluated by image techniques. 
Feature population Number of 
patients 
Age 
years ± SD 
Histological 
studies 
Main conclusions Image 
technique 
Year Author 
Severe carotid stenosis 13  Y Plaque density on CT angiograms correlated with histologic 
findings 
CT 1999 T. Oliver (47) 
Neurological events 30  Y High correlation between CT findings and histopathology CT 2009 M. Das (48) 
Carotid artery stenotic disease 268 carotids  N The resultant sensitivity of CT stenosis screening for moderate 
stenosis is 75.0% with a specificity of 93.8%. 
CT 2006 E. Bartlett (49) 
Ischemic cerebrovascular disease 404 62 ± 14 N CT angiography allows the assessment of atherosclerotic carotid 
plaque surface 
CT 2009 T. Weert (50) 
Patients with symptoms in the anterior 
circulation 
346  N CT allows the assessment of features of plaque in low degree of 
stenosis 
CT 2011 P. Homburg (51) 
Patients with internal carotid artery 
stenosis 
428 (185 female 
/243 male) 
73.3 ± 10.4 N Association between VV and symptomatic individuals was 
significant 
(P = 0.011) 
CT 2013 J. Romero et al. (26) 
Patients with atherosclerotic carotid artery 
disease 
20  Y Histological evaluation showed kinetic modelling of dynamic 
contrast-enhanced MRI (CE-MRI) reflects the neovascularity 
(P < 0.001) 
MRI 2003 W. Kerwin et al. (52) 
Patients with symptomatic carotid disease 
and stenosis of more than 70% 
11 (4 female  
/7 males) 
68 ± 4 
 
Y Detection rate for each plaque component was above 80% MRI 2005 V. Cappendijk et al. (53)  
Patients with carotid stenosis 31 68 ± 9 Y Good agreement between in vivo MRI and histology for 
quantitative measurements of the main plaque components 
MRI 2005 T. Saam et al (54) 
Patients with lesions of carotid; 
Subjects with moderate disease 
25 males 
20 males 
66.3 ± 10.9 
71.3 ± 9.5 
Y Histological evaluation showed that adventitial VV was 
significantly correlated with the amount of neovasculature 
(P<0.01) 
MRI 2008 W. Kerwin et al. (55) 
Patients with carotid stenosis of 15% or 
greater in an intensive lipid therapy 
28 (18% 
female/ 
82% male) 
55 ± 6 N Intensive lipid therapy is associated with a significant reduction in 
K
trans
 
MRI 2011 L. Dong et al. (29) 
Patients with carotid plaque 64 (13 females/ 
51 male) 
66 ± 12 Y Patients with cardiovascular events showed significantly higher 
adventitial (P< 0.001); Carotid adventitial was negatively 
correlated with time since clinical event 
(Spearman's rho = -0.40, p = 0.003) 
MRI 2017 J. Wang et al. (56) 
Male patient with diabetes 1 53 N Showed the possibility to identify progression and regression of 
atherosclerosis in patients 
CEUS 2006 S. Feinstein (57) 
Patients with atherosclerotic carotid artery 
disease 
17 
(7 female  
/10 male) 
 Y Histological evaluation was correlated with the CEUS results 
(Spearman’s=0.68) 
 
CEUS 2007 F. Shah et al. (15) 
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Patients with carotid stenosis; 
Patients without artery plaque 
25 (80% male) 
15 (66.7% 
male) 
64.5 + 11.7 
70.6 + 7.7 
N Adventitial VV higher in patient with carotid artherosclerosis 
(P<0.001) 
CEUS 2009 M. Magnoni et al. (58) 
Asymptomatic cerebrovascular disease; 
Patients with symptomatic carotid artery 
stenosis 
64 
9 
67 ± 6 Y Histology assessment confirmed the presence of vascularization in 
all symptomatic plaque identified by the CEUS 
CEUS 2009 M. Giannoni et al. (59) 
Subjects with pre-existing cardiovascular 
disease and events 
147 (61% male) 64 ± 11 
 
N Adventitial VVwas associated with cardiovascular disease and 
events 
(P < 0.05) 
CEUS 2010 D. Staub et al. (60) 
Patients carotid atherosclerotic disease 27 (8 female  
/19 male) 
68.4 ± 9.72 Y CEUS measurements were well correlated with the histopathologic 
ratio 
(R2 = 0.7905) 
CEUS 2011 A. Hoogi et al. (11) 
Patients with internal carotid artery 
stenosis 
 
31 (7 female 
/24 male) 
71 ± 11 N Far wall of the common carotid artery was significantly more 
echogenic than the near wall at contrast agent doses 
(P < 0.001) 
CEUS 2012 A. Thapar et al. (37) 
Patients with a carotid artery stenosis 14 (4 female 
/10 male) 
67.6 ± 10.2 
 
Y CEUS results showed a significant correlation with histology, 
however, they refer brightness enhancement during CEUS in 
carotid atherosclerotic plaques may not always reflect the presence 
of VV 
(P = 0.018) 
CEUS 2013 M. Vavuranakis et al. 
(61) 
Control Group; 
 
Patients with diabetes without retinopathy; 
 
Patients with diabetes with retinopathy 
65 (34 female 
/31 male) 
56 (27 female 
/29 male) 
51 (29 female 
/22 male) 
50 [41; 57] 
 
58 [49; 67] 
 
60 [54; 67] 
N Type 2 diabetic patients with retinopathy showed increased 
angiogenesis of the VV carotid artery 
(P<0.0039) 
CEUS 2013 M. Arcidiacono et al. 
(62) 
Patients with carotid atherosclerotic 
disease and cardiovascular events 
45   N New quantitative methods for analysing CEUS were significantly 
correlated with visual scoring image 
(P < 0.01) 
CEUS 2013 Z. Akkus et al. (63) 
Patients without intraplaque 
neovascularization (IPN); 
Patients with IPN 
30 
 
59 
62.9 ± 10.1 
 
68.4 ± 9.65 
N IPN showed a trend for a history of cardiovascular disease 
(P<0.19) 
CEUS 2014 H. Kim et al. (64) 
Patients with no symptoms of carotid 
atherosclerotic diseases 
159 56.9 ± 8.7 N Females had significant more intraplaque neovascularization 
compared to males 
(P < 0.05) 
CEUS 2014 S. van den Oord et al. 
(65) 
Healthy subjects 65 (48% men) [30; 70] N Increase of carotid adventitial VV with age in individuals with zero 
risk for atheromatosis  
(P = 0.015) 
CEUS 2015 M. Arcidiacono et al. 
(66) 
Control; 
Diabetes without retinopathy; 
Diabetes with retinopathy 
78 
53 
60 
48 [40; 57] 
46 [39; 51] 
48 [42; 54] 
N Type 1 diabetic patients showed an increased angiogenesis of the 
VV of carotid compared with non-diabetic subjects 
CEUS 2015 E. Rubinat et al. (42) 
Chronic kidney disease patients without 
previous cardiovascular events 
Patients in stages 3-4; 
Patients in stage 5D; 
Healthy 
 
 
44 
37 
65 
 
 
59.5 
60.0 
49.0 
N Patients with cardiovascular events showed significantly higher 
adventitial was negatively correlated with time since clinical event 
after adjusting for age 
CEUS 2017 M. Arcidiacono et al. 
(44) 
Patients with high-grade carotid stenosis 17 
(61.2% females/ 
58.8% males) 
66 (58–76) Y Scores on the CEUS-based on the level classifications were 
correlated with the density of intraplaque vessels 
(P<0.05) 
CEUS 2017 C. Schmidt et al. (34) 
CT - Computed Tomography; MRI - Magnetic Resonance Imaging; CEUS - Contrast-enhanced ultrasonography; P – P-value; IPN: Intraplaque Neovascularization 
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Contrast-enhanced ultrasonography 
The initial use of ultrasound imaging for carotid plaque assessment did not include the use of contrast agents 
(74), which were a posterior addition to this imaging modality (75). CEUS uses an intravenous microbubble 
contrast agent. The contrast agent is an intraluminal tracer and can be used to obtain angiography-like images 
of the carotid arteries (16). Currently, CEUS is on the frontline of methodological development for carotid 
VVn assessment and plaque characterization. 
As is the case with CT and DCE-MRI, CEUS imaging measurements correlate well with features derived 
from histological analysis of carotid plaques (11,12,15,59,60). One of these studies specifically showed that 
adventitial VVn is significantly associated to cardiovascular diseases and past cardiovascular events (60). 
CEUS analysis revealed an increase in adventitial VVn with age, even in individuals with no apparent risk 
factors for atherosclerosis (66). In addition, CEUS examination revealed that females had significantly more 
presence of intra-plaque neovessels than males (65), and that higher VVn was associated to a history of 
cardiovascular disease (64). Other CEUS studies also highlighted increased VVn in Type 1 and 2 diabetic 
patients (42,76). 
5. Automatic methods for VV quantification 
Automatic computational solutions that are quantitative, accurate, and reproducible represent an important 
development for assessing intraplaque neovascularization and for assessing VVn in the carotid adventitia. The 
later marks the asymptomatic, pre-plaque, stages of atherosclerosis. Such computational solutions assist in 
removing human subjectivity from image analysis. 
Early automatic methods for plaque detection and analysis in CT images often required extensive manual 
adjustment, especially if image noise, calcification, or other artifacts were present in the images (77). Semi-
automated methods for segmenting vessel walls and identifying the carotid artery lumen were also developed 
for the analysis of CT images (77–80). Results obtained using those semi-automated methods strongly 
correlated with the results generated by manual analysis of the same images (78–80). They also strongly 
correlated with results from histological analysis of carotid endarterectomies (81), and could be used for 
automated, high accuracy, classification of plaque samples into asymptomatic and symptomatic (81). 
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Methods that (semi)automatically detect the lumen, the outer boundary, and the contours of the plaque in 
carotid are also important in the field of DCE-MRI. An early semi-automated method required the operator to 
select two points in the image that define the vessel segment of interest. The computer then automatically 
connected the two points, using the centre line of the vessel to delineate the boundaries of the lumen, and 
assess the severity of carotid atherosclerosis (67,82). More recent methods automatically trace the contours of 
the lumen, as well as the outer boundary of the vessel wall and the plaque components (68,83–85). Overall, 
automated analysis of DCE-MRI images performs on par with manual quantification of  images by the 
operator (82–85). 
Automated quantification methods to analyse CEUS images of adventitia VVn and plaque VVn are under 
development to further improve the accuracy of image interpretation and to decrease inter-operator variability 
(16,86). During the manual process for CEUS image quantification, the operator defines the regions to 
consider. In general, and for currently available contrast quantification tools, the regions of interest (ROI) 
cannot be the same between different frames of a CEUS movie. For each frame, a user has to draw a new ROI, 
making for a cumbersome process that is disproportionately time consuming and hard to reproduce exactly. 
Automating this analysis would significantly reduce the analysis and processing time.  
Image processing techniques that detect ROI in the ultrasound image can identify wall structure (46,87), 
presence or absence of plaque (88), or levels of VVn (46,89). These solutions improve accuracy of carotid 
plaque measurements and quantification of VVn, either in plaque or in asymptomatic artery walls. Artificial 
intelligence and machine learning algorithms for pattern recognition are also being used to analyse CEUS 
images (90). Recently, machine learning techniques have trained to identify symptomatic and asymptomatic 
carotid plaque, with accuracy and sensitivity above 90% (91), which is a promising result. 
6. Discussion 
Technical limitations and opportunities 
Improving the large scale applicability of CT imaging requires hardware developments that reduce the dose of 
contrast agent and radiation exposure, thus facilitating a more widespread use of the technology (92). 
Similarly, improving the large scale applicability of MRI imaging requires that the costs of the technology be 
reduced. In addition, technical developments are require to enable accurate MRI measurements of either 
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adventitial VV in thinner-walled blood vessel or small wall injuries (29,56). CEUS could also benefit from 
hardware and technological improvements. First, new contrast agents, with fewer and weaker side effects, need 
to be developed (17). Second, methods that correct the artifacts generated in this type of imaging and leading to 
an over estimation of VV are also needed. Third, hardware that decreases the influence of the operator on 
image acquisition is still lacking. 
Molecular image techniques allow studying perfusion routes in vessels, by timing the appearance of 
contrast and fluorescence in the vessels and neovessel (93). This feature could be helpful in designing 
experiments to understand the ―direction‖ of vascular neogenesis in pathological states and validate the theory 
whereby vascular inflammation begins in the adventitia and advances to the media and intima (3,9). 
Overall, and due to the limitations and features of each technique, a strategy that combine more than one 
technique will prove most valuable, as different techniques offer complementary information (93). 
Improving image analysis 
In general, computer-assisted analysis for better quantification of image parameters have been longstanding 
issues in the medical imaging field (94,95). Artificial intelligence based methods are increasingly being 
applied to cardiology to interpret complex data ranging from advanced imaging technologies. Advances in 
high-performance computing and the increasing accessibility of machine learning algorithms capable of 
performing complex tasks have heightened clinical interest in applying these techniques in research and 
clinical care (96). Recent advances in machine learning methods (ML) led to promising results in the 
automated interpretation of medical images and these ML could hold the key for the development of efficient 
and accurate applications for automated analysis of medical images (95,97–99). 
Routine care of cardiovascular patients accumulates large amounts of data in electronic health records. The 
use of significant amount of diverse data is crucial to develop ML for medical applications. ML techniques can 
be useful for different types of the problems using different approaches. Supervised learning approaches use 
data to develop a model that can then predict or classify new events, while unsupervised learning approaches 
identify relationships between variables. Both approaches have been used for carotid imaging in the last years. 
However, ultrasound imaging has been most used to develop ML that assess plaque and VV 
neovascularization.  
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Supervised and unsupervised MLM have been used to assess segmentation and characterize carotid plaques 
from ultrasound images (99,100). It must be stressed that unsupervised MLM need to be validated in several 
independent cohorts, in order to confirm general cluster patterns and avoid potential classification biases 
(101). In supervised learning, small training datasets can lead to inaccurate decisions in testing datasets if the 
training datasets are biased. This means that training datasets for supervised learning should large and very 
well annotated. Developing the annotated datasets requires an enormous annotation effort by the experts. 
Due the time-consuming for feature engineering, used by unsupervised and supervised machine learning, 
deep learning (DL) has emerged as the leading technique for image task (102), DL algorithms automatically 
learn features through the implementation of multi-layer hierarchies for the purpose of classification (102). DL 
methods have successfully been used for example in early-stage atherosclerosis detection and automatic 
measurement of intima-media thickness (103), or to characterize carotid plaque composition (104). DL 
algorithms require substantial computational memory resources and this presents a potential limitation for the 
application of these methods. 
The accuracy of ML approaches is making them the best choice for assisted image analysis and 
interpretation, independently of the type of imaging method being used (94,105,106). These methods are 
expected to improve their performance, generating novel insights about pathological processes, enabling more 
precisely tailored treatment plans, and ultimately improving patient outcomes (94). 
Clinical and Health system outlook 
Atherosclerosis is a chronic inflammatory disease that leads to several acute cardiovascular complications with 
poor prognosis. Cardiovascular diseases remain the leading cause of morbidity and mortality worldwide. 
Considering its poor prognosis, understanding the pathophysiology of atherosclerosis and exploring potential 
means to discover populations at risk as well as preventing its progression remain of significant importance. 
Carotid imaging has focused mostly on the detection of atherosclerotic plaque and on the evaluation of its 
composition and structure. As the community becomes better at assessing these two aspects of a patient using 
imaging methods, we will become better at stratifying cardiovascular risk assessment and at personalizing 
treatment. Nevertheless, detection of biomarkers for early onset of atherosclerosis can have a big impact on the 
prevention and treatment of this disease group. One such biomarker is VVn before plaque formation. It seems 
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likely that better methods for quantifying this biomarker could have a strong impact on the evaluation of 
cardiovascular risk and personalization of preventive measures to reduce that risk. 
Additionally, a more widespread use of accurate non-invasive image techniques will help to better 
characterize the physiopathological dynamics of adventitial VVn, which is still a poorly understood process 
(2). This improved characterization will increase our understanding of the origin and evolution of 
atherosclerotic processes and cardiovascular diseases. For these reasons alone, the application of progressively 
better, more efficient and more economic non-invasive image techniques in cardiovascular screening programs 
is likely to have a big societal impact. 
7. Conclusions 
Important efforts are underway to understand the impact of VVn in vascular health and disease. A large 
fraction of these efforts focus on developing non-invasive imaging methods to assess carotid plaque. 
Quantification of VVn remains a major issue, as our ability to perform this assessment in vivo is still limited. 
To improve that ability, efforts should focus on further developing new imaging methodologies and automated 
image analysis algorithms. Improvements in these areas could potentially impact the clinician’s ability to 
stratify patients according to their risk levels and to better identify and treat individuals with premature 
cardiovascular disease (107). 
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